Key Clinical Points Asthma in Adults Asthma guidelines state that a definitive diagnosis of
asthma should be based on the presence of characteristic respiratory symptoms such as …

Drugs available for asthma treatment in the first decades of the 20th century
(sympathomimetic agents such as oral ephedrine, intravenous adrenaline, or inhaled …

Optimal evidence-based clinical practice requires systematic summaries of the best
available evidence, including ratings of the quality of that evidence, and is facilitated by the …

Using a therapeutic strategy that is free from traditional diagnostic labels and based on the
identification of “treatable traits”(TTs), which are influential in clinical presentations in each …

A significant number of patients with asthma remain uncontrolled despite treatment with
inhaled corticosteroids (ICS) and long‐acting β2 adrenergic bronchodilators (LABA). The …

Several current guidelines/strategies outline a treatment approach to asthma, which
primarily consider the goals of improving lung function and quality of life and reducing …

Pulmonary drug delivery is complex due to several challenges including disease-, patient-,
and clinicians-related factors. Although many inhaled medications are available in aerosol …

The landscape of asthma has considerably changed in the last decade. Effective
medications and inhaler devices have been developed and integrated into the asthma …

Purpose A systematic review and meta-analysis to determine the efficacy of long-acting
muscarinic antagonist (LAMA) in patients with asthma-COPD overlap (ACO) was conducted …

Purpose Tumor necrosis factor-like ligand 1A (TL1A), especially its secreted form, has been
shown to contribute to eosinophilic inflammation and mucus production, cardinal features of …